ALXN

Alexion Pharmaceuticals, Inc. News Headlines

$188.15
*  
1.38
0.73%
Get ALXN Alerts
*Delayed - data as of Dec. 22, 2014  -  Find a broker to begin trading ALXN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALXN After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Nasdaq 100 Movers: TSLA, VRTX
10/13/2014 12:44:02 PM - BNK Invest


The 5 Richest States in America
10/11/2014 7:45:11 AM - Motley Fool


Alexion Pharma Appoints Leonard Bell As Chairman
10/9/2014 7:34:00 AM - RTT News


Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola Update - Analyst Blog
10/8/2014 7:14:00 AM - Zacks.com


Max Link, Board Chairman at Alexion and CytRx, Dies at 74
10/7/2014 5:42:00 PM - Dow Jones Business News


Stock Market News for October 06, 2014 - Market News
10/6/2014 9:10:00 AM - Zacks.com


Alexion Pharmaceuticals (ALXN) in Focus: Stock Rises 6.0% - Tale of the Tape
10/6/2014 7:44:00 AM - Zacks.com


Stocks Holding On To Strong Gains Following Upbeat Jobs Data - U.S. Commentary
10/3/2014 12:10:00 PM - RTT News


Proshares UltraPro QQQ Experiences Big Inflow
10/2/2014 10:02:47 AM - BNK Invest


Insider Buys And Sells: American Eagle Outfitters, Facebook
9/28/2014 10:50:00 AM - Seeking Alpha


Stocks Move Mostly Higher As Traders Hunt For Bargains - U.S. Commentary
9/24/2014 12:14:00 PM - RTT News


Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA - Analyst Blog
9/24/2014 10:05:00 AM - Zacks.com


Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog
9/22/2014 2:20:00 PM - Zacks.com


Noteworthy ETF Inflows: TQQQ, ATVI, AKAM, ALXN
9/18/2014 9:54:50 AM - BNK Invest


3 Hot Ways to Play the Biotechnology Bonanza
9/17/2014 9:52:17 AM - InvestorPlace Media


If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits
9/16/2014 8:00:00 AM - Seeking Alpha


Is Intercept Pharmaceuticals Building The Next Great Specialty Franchise?
9/15/2014 2:30:00 PM - Seeking Alpha


Alexion's Asfotase Alfa Gets Japanese Orphan Drug Status - Analyst Blog
9/9/2014 4:30:00 PM - Zacks.com


Alexion Pharmaceuticals' Soliris Wins NICE Backing for aHUS - Analyst Blog
9/4/2014 4:00:00 PM - Zacks.com


IBB, CELG, BIIB, ALXN: ETF Outflow Alert
9/2/2014 10:18:23 AM - BNK Invest


Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog
8/29/2014 5:10:00 PM - Zacks.com


Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog
8/29/2014 3:55:00 PM - Zacks.com


Repros Reports Encouraging Late-Stage Data on Androxal - Analyst Blog
8/28/2014 3:30:00 PM - Zacks.com


Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog
8/27/2014 9:32:00 AM - Zacks.com


Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update
8/23/2014 10:34:00 AM - Seeking Alpha